Replay available

Coherus Oncology, Inc. (CHRS) Q1 2026 Earnings Call

Coherus Oncology, Inc. (NASDAQ: CHRS) Q1 2026 earnings conference call, held 2026-05-11. Replay captured from the company's public earnings webcast.

Mon, May 11, 2026 at 5:00 PMendedReplay
Coherus Oncology, Inc. (CHRS) Q1 2026 Earnings Call

Hosted by

Featured presenters

Denny Lancer

Chief Executive Officer

Dr. Rosh Dias

Chief Medical Officer

Samira Ghori-Gokhar

Chief Commercial Officer

Brian McMichael

Chief Financial Officer

Jay Olson

Analyst, Oppenheimer

Paul Jeng

Analyst, Guggenheim

Brian Cheng

Analyst, JPMorgan

Mike Nedekovich

Analyst, TD Cowen

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Coherus Oncology, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.855 Good day and thank you for standing by. Welcome to the Q1 2026 00:00:05.878 -- 00:00:09.922 Coheris Oncology Inc. Earnings Conference Call. 00:00:09.922 -- 00:00:14.488 At this time, all participants are in a listen-only mode. 00:00:14.488 -- 00:00:18.853 After the speaker's presentation, there will be a question and answer session. 00:00:18.853 -- 00:00:24.099 To ask a question during this session, you will need to press star 1, 1 00:00:24.099 -- 00:00:29.145 on your telephone. You will then hear an automated message advising your hand is 00:00:29.145 -- 00:00:34.196 raised. To withdraw your question, please press star 1, 1 00:00:34.196 -- 00:00:38.502 again. Please be advised that today's conference is being recorded. 00:00:38.502 -- 00:00:43.529 I would now like to hand the conference over to your speaker today, Carrie Graham. 00:00:43.529 -- 00:00:44.450 Please go ahead. 00:00:44.450 -- 00:00:46.313 Thank 00:00:46.313 -- 00:00:52.181 you, Heidi. Good afternoon, and welcome to Coherent Oncology's first quarter 2026 earnings 00:00:52.181 -- 00:00:57.309 conference call. Joining me today to discuss our results are Denny Lancer, Chief Executive 00:00:57.309 -- 00:01:02.126 Officer of Coherent, Dr. Rosh Dias, Chief Medical Officer, Dr. 00:01:02.126 -- 00:01:06.911 Theresa Lavallee, Chief Scientific and Development Officer, Samira Ghori-Gokhar, Chief 00:01:06.911 -- 00:01:11.436 Commercial Officer, and Brian McMichael, Chief Financial Officer. 00:01:11.436 -- 00:01:15.220 Before we get started, I would like to remind you that today's call includes forward-looking 00:01:15.220 -- 00:01:20.405 statements regarding COHER's current expectations about future events. 00:01:20.405 -- 00:01:25.310 Actual results may vary significantly, and w...